Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Sorin reported flat results for Q1, but sees expected FDA approval of its Perceval sutureless aortic valve as helping to accelerate growth in the 2015 second half. Results from three new studies of the implant underscore its potential market potential.
Endoscope maker EndoChoice, fresh off a $57 million funding round, registers for an initial public offering worth $115 million.
EndoChoice said today that it filed for an initial public offering that could fetch as much as $115 million, scarcely 2 months after pulling down a $57 million funding round for its Fuse full-spectrum endoscope.